Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

BICNU

CARMUSTINE

Standard Dose
100MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview BICNU is listed in Drugs@FDA under application 017422 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient CARMUSTINE Form and strength INJECTABLE;INJECTION - 100MG/VIAL Sponsor AVET LIFESCIENCES Submission history Latest submission status date: 2021-04-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview BICNU is listed in Drugs@FDA under application 017422 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient CARMUSTINE Form and strength INJECTABLE;INJECTION - 100MG/VIAL Sponsor AVET LIFESCIENCES Submission history Latest submission status date: 2021-04-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.
BICNU (CARMUSTINE) | Drug Monograph | MedicHelpline